ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Eduardo Cazap, MD PhD (President SLACOM)

ISSN: 1754-6605

Submit article

582-effectiveness-and-safety-of-monoclonal-antibodies-for-metastatic-colorectal-cancer-treatment-systematic-review-and-meta-analysis

Review: Effectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysis

Bruno Rosa, José Paulo de Jesus, Eduardo L de Mello, Daniel Cesar, Mauro M Correia

15 Oct 2015

https://doi.org/10.3332/ecancer.2015.582

Abstract | Full Article | PDF | Portuguese

568-repurposing-drugs-in-oncology-redo-nitroglycerin-as-an-anti-cancer-agent

Clinical Study: Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent

Vidula Sukhatme, Gauthier Bouche, Lydie Meheus, Vikas P Sukhatme, Pan Pantziarka

27 Aug 2015

https://doi.org/10.3332/ecancer.2015.568

Abstract | Full Article | PDF

567-comparative-evaluation-of-triplet-antiemetic-schedule-versus-doublet-antiemetic-schedule-in-chemotherapy-induced-emesis-in-head-and-neck-cancer-patients

Research: Comparative evaluation of triplet antiemetic schedule versus doublet antiemetic schedule in chemotherapy-induced emesis in head and neck cancer patients

Pulkit Kaushal, Rajeev Atri, Abhishek Soni, Vivek Kaushal

25 Aug 2015

https://doi.org/10.3332/ecancer.2015.567

Abstract | Full Article | PDF

562-impact-of-immunohistochemistry-based-molecular-subtype-on-chemosensitivity-and-survival-in-hispanic-breast-cancer-patients-following-neoadjuvant-chemotherapy

Clinical Study: Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy

Rodolfo Gómez, Carlos Andrés Ossa, María Elvira Montoya, Carolina Echeverri, Gonzalo Ángel, Johana Ascuntar, Mauricio Borrero, Mónica Gil, Sabrina Herrera, Eduardo Gutiérrez, Fernando Herazo, Alejo Jiménez, Jorge Madrid, Pedro Alejandro Reyes, Lina Zuluaga, Héctor García

6 Aug 2015

https://doi.org/10.3332/ecancer.2015.562

Abstract | Full Article | PDF